Expressions of interest are sought from investigators with access to existing samples and/or patient cohorts of individuals with ≥2 T1D autoantibodies to develop improved prognostic risk scores of progression and/or to develop new or improved screening assays. The translational potential of the investigations should be highlighted and thus, only research plans involving human samples will be considered.
The major focus of this EOI will be to identify candidate biomarkers that:
– Stage type 1 diabetes in the at-risk setting
– Predict risk/rate of progression
– Serve as surrogates of efficacy of preventive interventions
– Allow for inclusion/exclusion in clinical trials in the at-risk setting
Investigators with ideas or resources that might benefit this initiative should also submit their ideas via an expression of interest. Collaborative projects, where possible, to interrogate common sample sets are encouraged, and higher budgets may be allowed for such projects. Please contact JDRF prior to submission of an EOI for approval of such projects. JDRF recently released a request for letters of intent (LOIs) for Biomarkers of Pancreatic Beta Cell Stress and Health. This EOI is not meant as a replication of that LOI and EOIs in relation to beta cell stress and health will be considered only if they are relevant to the prevention setting. Furthermore, EOIs with a focus on autoantibody negative individuals only will not be considered.
Cal comunicar abans del 21 d’octubre de 2013 que es vol participar a la convocatòria, enviant un e-mail a firstname.lastname@example.org . Termini: 22 d’octubre de 2013. L’IISPV gestiona les ajudes dels seus investigadors, no és l’entitat convocant.
o Expression of Interest: …………………………. November 1, 2013
o EOI Notification ……………………………………. November 8, 2013
o Application Due Date: …………………………… December 18, 2013
o Response to Applicants Date: ………………. March 2014
o Earliest Anticipated Start Date: …………….. June 2014
Omple el següent formulari per rebre més informació:
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
|cookielawinfo-checkbox-analytics||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".|
|cookielawinfo-checkbox-functional||11 months||The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".|
|cookielawinfo-checkbox-necessary||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".|
|cookielawinfo-checkbox-others||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.|
|cookielawinfo-checkbox-performance||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".|
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.